Your drug. Our expertise. A successful combination to manage your clinical trials
CTA is a clinical trial network spread across multiple sites. CTA provides a fully comprehensive oncology clinical trials service that includes the conduct of single or multisite clinical trials, ethics submissions, research governance and clinical development advisory services. CTA’s strength lies in the collective technical and intellectual expertise of its members and the sharing of their resources.
CTA’s current members are:
Every day that a potential new medicine spends in development translates to significant loss of revenue and loss of competitive advantage for the company involved. Australia’s unique regulatory environment together with CTA’s efficient management structure means that it is possible to receive approval to initiate a new trial in 60 days from submission of data.
Our customers include member research groups,biotechnology firms, and large pharmaceutical companies.
Click here to read more about the services we offer…